Bhaskara Srividya
Department of Radiation Oncology, Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine;
J Vis Exp. 2016 Jan 14(107):e53647. doi: 10.3791/53647.
Histone deacetylases 1 and 2 (HDAC1,2) localize to the sites of DNA replication. In the previous study, using a selective inhibitor and a genetic knockdown system, we showed novel functions for HDAC1,2 in replication fork progression and nascent chromatin maintenance in mammalian cells. Additionally, we used a BrdU-ChIP-Slot-Western technique that combines chromatin immunoprecipitation (ChIP) of bromo-deoxyuridine (BrdU)-labeled DNA with slot blot and Western analyses to quantitatively measure proteins or histone modification associated with nascent DNA. Actively dividing cells were treated with HDAC1,2 selective inhibitor or transfected with siRNAs against Hdac1 and Hdac2 and then newly synthesized DNA was labeled with the thymidine analog bromodeoxyuridine (BrdU). The BrdU labeling was done at a time point when there was no significant cell cycle arrest or apoptosis due to the loss of HDAC1,2 functions. Following labeling of cells with BrdU, chromatin immunoprecipitation (ChIP) of histone acetylation marks or the chromatin-remodeler was performed with specific antibodies. BrdU-labeled input DNA and the immunoprecipitated (or ChIPed) DNA was then spotted onto a membrane using the slot blot technique and immobilized using UV. The amount of nascent DNA in each slot was then quantitatively assessed using Western analysis with an anti-BrdU antibody. The effect of loss of HDAC1,2 functions on the levels of newly synthesized DNA-associated histone acetylation marks and chromatin remodeler was then determined by normalizing the BrdU-ChIP signal obtained from the treated samples to the control samples.
组蛋白去乙酰化酶1和2(HDAC1,2)定位于DNA复制位点。在先前的研究中,我们使用一种选择性抑制剂和基因敲低系统,揭示了HDAC1,2在哺乳动物细胞复制叉进展和新生染色质维持中的新功能。此外,我们使用了一种BrdU-ChIP-Slot-Western技术,该技术将溴脱氧尿苷(BrdU)标记的DNA的染色质免疫沉淀(ChIP)与狭缝印迹和Western分析相结合,以定量测量与新生DNA相关的蛋白质或组蛋白修饰。用HDAC1,2选择性抑制剂处理活跃分裂的细胞,或用针对Hdac1和Hdac2的小干扰RNA(siRNA)转染细胞,然后用胸苷类似物溴脱氧尿苷(BrdU)标记新合成的DNA。BrdU标记在由于HDAC1,2功能丧失而没有明显细胞周期停滞或凋亡的时间点进行。在用BrdU标记细胞后,用特异性抗体对组蛋白乙酰化标记或染色质重塑因子进行染色质免疫沉淀(ChIP)。然后使用狭缝印迹技术将BrdU标记的输入DNA和免疫沉淀(或ChIP)的DNA点样到膜上,并用紫外线固定。然后使用抗BrdU抗体通过Western分析定量评估每个狭缝中新生DNA的量。通过将处理样品获得的BrdU-ChIP信号与对照样品进行归一化,确定HDAC1,2功能丧失对新合成的DNA相关组蛋白乙酰化标记和染色质重塑因子水平的影响。